1 Report Overview

1.1 Study Scope and Definition

1.2 Research Methodology

1.2.1 Methodology/Research Approach

1.2.2 Data Source

1.3 Key Market Segments

1.4 Players Covered: Ranking by Companion Cancer Diagnostics Revenue

1.5 Market Analysis by Type

1.5.1 Global Companion Cancer Diagnostics Market Size Growth Rate by Type: 2021 VS 2027

1.5.2 Breast Cancer

1.5.3 Lung Cancer

1.5.4 Colorectal Cancer

1.5.5 Melanoma

1.5.6 Gastric Cancer

1.6 Market by Application

1.6.1 Global Companion Cancer Diagnostics Market Share by Application: 2022-2027

1.6.2 Pharmaceutical & Biopharmaceutical Companies

1.6.3 Reference Laboratories

1.6.4 CROs

1.6.5 Others

1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections

1.7.2 Covid-19 Impact: Commodity Prices Indices

1.7.3 Covid-19 Impact: Global Major Government Policy

1.8 Study Objectives

1.9 Years Considered

2 Global Companion Cancer Diagnostics Market Trends and Growth Strategy

2.1 Market Top Trends

2.2 Market Drivers

2.3 Market Challenges

2.4 Porters Five Forces Analysis

2.5 Market Growth Strategy

2.6 SWOT Analysis

3 Global Companion Cancer Diagnostics Market Players Profiles

3.1 F. Hoffmann-La Roche

3.1.1 F. Hoffmann-La Roche Company Profile

3.1.2 F. Hoffmann-La Roche Companion Cancer Diagnostics Product Specification

3.1.3 F. Hoffmann-La Roche Companion Cancer Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.2 Myriad Genetics

3.2.1 Myriad Genetics Company Profile

3.2.2 Myriad Genetics Companion Cancer Diagnostics Product Specification

3.2.3 Myriad Genetics Companion Cancer Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.3 Abbott Laboratories

3.3.1 Abbott Laboratories Company Profile

3.3.2 Abbott Laboratories Companion Cancer Diagnostics Product Specification

3.3.3 Abbott Laboratories Companion Cancer Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.4 Agilent Technologies

3.4.1 Agilent Technologies Company Profile

3.4.2 Agilent Technologies Companion Cancer Diagnostics Product Specification

3.4.3 Agilent Technologies Companion Cancer Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.5 bioMrieuxSA

3.5.1 bioMrieuxSA Company Profile

3.5.2 bioMrieuxSA Companion Cancer Diagnostics Product Specification

3.5.3 bioMrieuxSA Companion Cancer Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.6 QIAGEN

3.6.1 QIAGEN Company Profile

3.6.2 QIAGEN Companion Cancer Diagnostics Product Specification

3.6.3 QIAGEN Companion Cancer Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.7 Danaher Corporation

3.7.1 Danaher Corporation Company Profile

3.7.2 Danaher Corporation Companion Cancer Diagnostics Product Specification

3.7.3 Danaher Corporation Companion Cancer Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.8 Almac Group

3.8.1 Almac Group Company Profile

3.8.2 Almac Group Companion Cancer Diagnostics Product Specification

3.8.3 Almac Group Companion Cancer Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Companion Cancer Diagnostics Market Competition by Market Players

4.1 Global Companion Cancer Diagnostics Production Capacity Market Share by Market Players (2016-2021)

4.2 Global Companion Cancer Diagnostics Revenue Market Share by Market Players (2016-2021)

4.3 Global Companion Cancer Diagnostics Average Price by Market Players (2016-2021)

5 Global Companion Cancer Diagnostics Production by Regions (2016-2021)

5.1 North America

5.1.1 North America Companion Cancer Diagnostics Market Size (2016-2021)

5.1.2 Companion Cancer Diagnostics Key Players in North America (2016-2021)

5.1.3 North America Companion Cancer Diagnostics Market Size by Type (2016-2021)

5.1.4 North America Companion Cancer Diagnostics Market Size by Application (2016-2021)

5.2 East Asia

5.2.1 East Asia Companion Cancer Diagnostics Market Size (2016-2021)

5.2.2 Companion Cancer Diagnostics Key Players in East Asia (2016-2021)

5.2.3 East Asia Companion Cancer Diagnostics Market Size by Type (2016-2021)

5.2.4 East Asia Companion Cancer Diagnostics Market Size by Application (2016-2021)

5.3 Europe

5.3.1 Europe Companion Cancer Diagnostics Market Size (2016-2021)

5.3.2 Companion Cancer Diagnostics Key Players in Europe (2016-2021)

5.3.3 Europe Companion Cancer Diagnostics Market Size by Type (2016-2021)

5.3.4 Europe Companion Cancer Diagnostics Market Size by Application (2016-2021)

5.4 South Asia

5.4.1 South Asia Companion Cancer Diagnostics Market Size (2016-2021)

5.4.2 Companion Cancer Diagnostics Key Players in South Asia (2016-2021)

5.4.3 South Asia Companion Cancer Diagnostics Market Size by Type (2016-2021)

5.4.4 South Asia Companion Cancer Diagnostics Market Size by Application (2016-2021)

5.5 Southeast Asia

5.5.1 Southeast Asia Companion Cancer Diagnostics Market Size (2016-2021)

5.5.2 Companion Cancer Diagnostics Key Players in Southeast Asia (2016-2021)

5.5.3 Southeast Asia Companion Cancer Diagnostics Market Size by Type (2016-2021)

5.5.4 Southeast Asia Companion Cancer Diagnostics Market Size by Application (2016-2021)

5.6 Middle East

5.6.1 Middle East Companion Cancer Diagnostics Market Size (2016-2021)

5.6.2 Companion Cancer Diagnostics Key Players in Middle East (2016-2021)

5.6.3 Middle East Companion Cancer Diagnostics Market Size by Type (2016-2021)

5.6.4 Middle East Companion Cancer Diagnostics Market Size by Application (2016-2021)

5.7 Africa

5.7.1 Africa Companion Cancer Diagnostics Market Size (2016-2021)

5.7.2 Companion Cancer Diagnostics Key Players in Africa (2016-2021)

5.7.3 Africa Companion Cancer Diagnostics Market Size by Type (2016-2021)

5.7.4 Africa Companion Cancer Diagnostics Market Size by Application (2016-2021)

5.8 Oceania

5.8.1 Oceania Companion Cancer Diagnostics Market Size (2016-2021)

5.8.2 Companion Cancer Diagnostics Key Players in Oceania (2016-2021)

5.8.3 Oceania Companion Cancer Diagnostics Market Size by Type (2016-2021)

5.8.4 Oceania Companion Cancer Diagnostics Market Size by Application (2016-2021)

5.9 South America

5.9.1 South America Companion Cancer Diagnostics Market Size (2016-2021)

5.9.2 Companion Cancer Diagnostics Key Players in South America (2016-2021)

5.9.3 South America Companion Cancer Diagnostics Market Size by Type (2016-2021)

5.9.4 South America Companion Cancer Diagnostics Market Size by Application (2016-2021)

5.10 Rest of the World

5.10.1 Rest of the World Companion Cancer Diagnostics Market Size (2016-2021)

5.10.2 Companion Cancer Diagnostics Key Players in Rest of the World (2016-2021)

5.10.3 Rest of the World Companion Cancer Diagnostics Market Size by Type (2016-2021)

5.10.4 Rest of the World Companion Cancer Diagnostics Market Size by Application (2016-2021)

6 Global Companion Cancer Diagnostics Consumption by Region (2016-2021)

6.1 North America

6.1.1 North America Companion Cancer Diagnostics Consumption by Countries

6.1.2 United States

6.1.3 Canada

6.1.4 Mexico

6.2 East Asia

6.2.1 East Asia Companion Cancer Diagnostics Consumption by Countries

6.2.2 China

6.2.3 Japan

6.2.4 South Korea

6.3 Europe

6.3.1 Europe Companion Cancer Diagnostics Consumption by Countries

6.3.2 Germany

6.3.3 United Kingdom

6.3.4 France

6.3.5 Italy

6.3.6 Russia

6.3.7 Spain

6.3.8 Netherlands

6.3.9 Switzerland

6.3.10 Poland

6.4 South Asia

6.4.1 South Asia Companion Cancer Diagnostics Consumption by Countries

6.4.2 India

6.5 Southeast Asia

6.5.1 Southeast Asia Companion Cancer Diagnostics Consumption by Countries

6.5.2 Indonesia

6.5.3 Thailand

6.5.4 Singapore

6.5.5 Malaysia

6.5.6 Philippines

6.6 Middle East

6.6.1 Middle East Companion Cancer Diagnostics Consumption by Countries

6.6.2 Turkey

6.6.3 Saudi Arabia

6.6.4 Iran

6.6.5 United Arab Emirates

6.7 Africa

6.7.1 Africa Companion Cancer Diagnostics Consumption by Countries

6.7.2 Nigeria

6.7.3 South Africa

6.8 Oceania

6.8.1 Oceania Companion Cancer Diagnostics Consumption by Countries

6.8.2 Australia

6.9 South America

6.9.1 South America Companion Cancer Diagnostics Consumption by Countries

6.9.2 Brazil

6.9.3 Argentina

6.10 Rest of the World

6.10.1 Rest of the World Companion Cancer Diagnostics Consumption by Countries

7 Global Companion Cancer Diagnostics Production Forecast by Regions (2022-2027)

7.1 Global Forecasted Production of Companion Cancer Diagnostics (2022-2027)

7.2 Global Forecasted Revenue of Companion Cancer Diagnostics (2022-2027)

7.3 Global Forecasted Price of Companion Cancer Diagnostics (2022-2027)

7.4 Global Forecasted Production of Companion Cancer Diagnostics by Region (2022-2027)

7.4.1 North America Companion Cancer Diagnostics Production, Revenue Forecast (2022-2027)

7.4.2 East Asia Companion Cancer Diagnostics Production, Revenue Forecast (2022-2027)

7.4.3 Europe Companion Cancer Diagnostics Production, Revenue Forecast (2022-2027)

7.4.4 South Asia Companion Cancer Diagnostics Production, Revenue Forecast (2022-2027)

7.4.5 Southeast Asia Companion Cancer Diagnostics Production, Revenue Forecast (2022-2027)

7.4.6 Middle East Companion Cancer Diagnostics Production, Revenue Forecast (2022-2027)

7.4.7 Africa Companion Cancer Diagnostics Production, Revenue Forecast (2022-2027)

7.4.8 Oceania Companion Cancer Diagnostics Production, Revenue Forecast (2022-2027)

7.4.9 South America Companion Cancer Diagnostics Production, Revenue Forecast (2022-2027)

7.4.10 Rest of the World Companion Cancer Diagnostics Production, Revenue Forecast (2022-2027)

7.5 Forecast by Type and by Application (2022-2027)

7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)

7.5.2 Global Forecasted Consumption of Companion Cancer Diagnostics by Application (2022-2027)

8 Global Companion Cancer Diagnostics Consumption Forecast by Regions (2022-2027)

8.1 North America Forecasted Consumption of Companion Cancer Diagnostics by Country

8.2 East Asia Market Forecasted Consumption of Companion Cancer Diagnostics by Country

8.3 Europe Market Forecasted Consumption of Companion Cancer Diagnostics by Countriy

8.4 South Asia Forecasted Consumption of Companion Cancer Diagnostics by Country

8.5 Southeast Asia Forecasted Consumption of Companion Cancer Diagnostics by Country

8.6 Middle East Forecasted Consumption of Companion Cancer Diagnostics by Country

8.7 Africa Forecasted Consumption of Companion Cancer Diagnostics by Country

8.8 Oceania Forecasted Consumption of Companion Cancer Diagnostics by Country

8.9 South America Forecasted Consumption of Companion Cancer Diagnostics by Country

8.10 Rest of the world Forecasted Consumption of Companion Cancer Diagnostics by Country

9 Global Companion Cancer Diagnostics Sales by Type (2016-2027)

9.1 Global Companion Cancer Diagnostics Historic Market Size by Type (2016-2021)

9.2 Global Companion Cancer Diagnostics Forecasted Market Size by Type (2022-2027)

10 Global Companion Cancer Diagnostics Consumption by Application (2016-2027)

10.1 Global Companion Cancer Diagnostics Historic Market Size by Application (2016-2021)

10.2 Global Companion Cancer Diagnostics Forecasted Market Size by Application (2022-2027)

11 Global Companion Cancer Diagnostics Manufacturing Cost Analysis

11.1 Companion Cancer Diagnostics Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.3 Manufacturing Process Analysis of Companion Cancer Diagnostics

12 Global Companion Cancer Diagnostics Marketing Channel, Distributors, Customers and Supply Chain

12.1 Marketing Channel

12.2 Companion Cancer Diagnostics Distributors List

12.3 Companion Cancer Diagnostics Customers

12.4 Companion Cancer Diagnostics Supply Chain Analysis

13 Analyst's Viewpoints/Conclusions

14 Disclaimer